Literature DB >> 1921500

Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy.

M D Silverstein1, C B Stocking, J P Antel, J Beckwith, R P Roos, M Siegler.   

Abstract

To identify the wishes of patients with amyotrophic lateral sclerosis (ALS) for information, participation in decision making, and life-sustaining therapy and to determine whether these wishes are stable over time, we conducted a prospective survey (baseline and 6-month follow-up interviews) of 38 consecutive patients with an established diagnosis of ALS at the University of Chicago Motor Neuron Disease Clinic. Demographic data, clinical stage of ALS, illness experience, wishes for information, and desires for participating in decisions about life-sustaining therapy were elicited. Patients readily expressed their wishes for specific information on communication aids and ventilator care for respiratory failure. Demographic, socioeconomic, and clinical characteristics did not predict patients' desires for information and decision making. The preferences for information and participation in decisions were stable during the 6-month study period, whereas preferences for cardiopulmonary resuscitation in two hypothetical circumstances were less stable. Changes were unrelated to demographic or clinical characteristics of the patients. Because many patients with ALS change their preferences for life-sustaining therapy, advance directives for end-of-life care must be reevaluated periodically.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; Professional Patient Relationship

Mesh:

Year:  1991        PMID: 1921500     DOI: 10.1016/s0025-6196(12)61577-8

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  17 in total

1.  Prospective study of health status preferences and changes in preferences over time in older adults.

Authors:  Terri R Fried; Amy L Byers; William T Gallo; Peter H Van Ness; Virginia R Towle; John R O'Leary; Joel A Dubin
Journal:  Arch Intern Med       Date:  2006-04-24

2.  Advance care planning for patients with amyotrophic lateral sclerosis.

Authors:  Benjamin H Levi; Zachary Simmons; Courtney Hanna; Allyson Brothers; Erik Lehman; Elana Farace; Megan Bain; Renee Stewart; Michael J Green
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-03-05       Impact factor: 4.092

3.  Advance directives: are they an advance? Advance Directives Seminar Group, Centre for Bioethics, University of Toronto.

Authors: 
Journal:  CMAJ       Date:  1992-01-15       Impact factor: 8.262

Review 4.  Diagnostic investigation and multidisciplinary management in motor neuron disease.

Authors:  J A Rocha; C Reis; F Simões; J Fonseca; J Mendes Ribeiro
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

5.  Motor neurone disease.

Authors:  J M Shneerson
Journal:  BMJ       Date:  1996-08-03

6.  Accepting or declining non-invasive ventilation or gastrostomy in amyotrophic lateral sclerosis: patients' perspectives.

Authors:  L P Greenaway; N H Martin; V Lawrence; A Janssen; A Al-Chalabi; P N Leigh; L H Goldstein
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

7.  What are cancer patients' preferences about treatment at the end of life, and who should start talking about it? A comparison with healthy people and medical staff.

Authors:  S Sahm; R Will; G Hommel
Journal:  Support Care Cancer       Date:  2005-01-19       Impact factor: 3.603

Review 8.  Patient autonomy in emergency medicine.

Authors:  A C Naess; R Foerde; P A Steen
Journal:  Med Health Care Philos       Date:  2001

9.  Communications research.

Authors:  V Entwistle; I Watt; H Buchan
Journal:  CMAJ       Date:  1995-10-15       Impact factor: 8.262

10.  Truth-telling in clinical practice.

Authors:  P C Hébert
Journal:  Can Fam Physician       Date:  1994-12       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.